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Summary--In normal mouse Leydig cells, steady state levels of mRNA of CYPIlA, 
31~-hydroxysteroid dehydrogenase A 5- > A4-isomerase (38 HSD), and CYP17 are differentially 
regulated. There is high basal expression of 3/~HSD and CYPI IA mRNA, while expression 
of CYPI7 mRNA is absolutely dependent on cAMP stimulation, cAMP is required for 
maximal expression of all three enzymes. The expression of CYP11A in normal mouse Leydig 
cells is repressed by glucocorticoids. Glucocorticoids also repress both basal and cAMP-in- 
duced expression of 3]~HSD mRNA, but do not repress the synthesis or mRNA levels of 
CYPI7. cAMP induction of 3/~HSD mRNA can be observed only when aminoglutethimide 
(AG), an inhibitor of cholesterol metabolism, is added to the Leydig cell cultures. The addition 
of AG also markedly increases cAMP induction of CYP17 mRNA levels. Addition of 
testosterone or the androgen agonist, mibolerone, to cAMP plus AG treated cultures reduced 
3~HSD and CYP17 mRNA levels to levels comparable to those observed when cells were 
treated with cAMP only. These data indicate that testosterone acting via the androgen receptor 
represses expression of both CYPI7 and 3~HSD. The role of protein synthesis in mediating 
the cAMP induction of 3~HSD, CYPI7 and CYPI1A was examined. The addition of 
cycloheximide, an inhibitor of protein synthesis, to cAMP treated cultures for 24 h completely 
suppressed both constitutive and cAMP-induced 3~HSD mRNA levels. Cycloheximide also 
repressed cAMP-induced levels of CYPI7 to 12% of levels observed in the absence of 
cycloheximide. In sharp contrast, treatment for 24 h with cycloheximide did not suppress 
cAMP induction of CYP1 IA mRNA, but reduced basal levels by approx. 50%. These data 
indicate that newly synthesized protein(s) are required for cAMP induction of CYPI7 and 
3]~HSD mRNA levels, but not for CYP11A mRNA. 
A mouse Cypl 7genomic clone containing the entire coding region plus 10 kb of 5' flanking 
region has been isolated. Fragments of 5' flanking sequences were subcloned into vectors 
containing the CAT reporter gene and transfected into MA-10 Leydig cells. Transfected cells 
were treated with cAMP and expression was determined by measuring CAT activity. A cAMP 
responsive element was identified in a region between -245 and -346 bp relative to the 
transcription initiation site of CyplT. Cotransfection into MA-10 Leydig cells of constructs 
containing 4.5 kb of Cypl7  5' flanking sequences together with a mouse androgen receptor 
expression vector demonstrate a dose dependent repression of cAMP-induced Cypl7  tran- 
scription by the androgen receptor. Studies with the mouse Cypl la  gene demonstrate that the 
5' flanking region of the gene contains sequences between 2.5 and 5 kb that are necessary for 
expression of mouse Cypl la  in Leydig cells but not in adrenal cells. 
INTRODUCTION 
Biosynthesis of  testosterone from cholesterol in 
Leydig cells involves the action of  four enzymes 
(Fig. 1). The initial rate-limiting step in this 
pathway is the conversion of  the C27 steroid, 
cholesterol, to the C:, steroid, pregnenolone, 
which is catalyzed by the cytochrome P450 
enzyme, cholesterol side-chain cleavage 
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(CYPl lA) .  This enzyme is located in the inner 
mitochondrial membrane.  Pregnenolone 
diffuses across the mitochondrial  membrane 
and is further metabolized by enzymes associ- 
ated with the smooth endoplasmic reticulum. In 
the mouse Leydig cell, pregnenolone is first 
converted to progesterone by the action 
of  3fl-hydroxysteroid dehydrogenase/A 5- > A 4- 
isomerase (3flHSD). The next reaction is cata- 
lyzed by the cytochrome P450 enzyme, CYP17. 
CYP17 catalyzes two reactions, 17~-hydroxyl- 
ation of  progesterone followed by cleavage of 
the C~7-20 bond to yield the C~9 steroid, an- 
drostenedione, the immediate precursor of  












Fig. 1. Steroid biosynthetic pathway in Leydig cells. P450~, 
cytochrome P450 cholesterol side-chain cleavage; P450el 7, 
cytochrome P45017=-hydroxylase/C=7.~o lyase; 3flHSD, 3fl- 
hydroxysteroid dehydrogenase/AS->A 4 isomerase; 17KSR, 
17 ketosteroid reductase. 
synthesis of testosterone is the reduction of the 
17 ketone of androstenedione by 17 ketosteroid 
reductase (17KSR). 
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This paper will focus on the regulation of 
expression of CYP11A, CYP17 and 3flHSD in 
mouse Leydig cell cultures by cyclic AMP 
(cAMP) and steroids as well as their tissue 
specific expression. Identification of a cAMP- 
responsive region in the mouse Cyp!  7 gene and 
repression of cAMP-induced expression of 
Cypl  7 by the mouse androgen receptor will be 
discussed as well as the identification of Leydig 
cell-specific sequences in the mouse Cyp l la  
gene. A review by Waterman et al. [1] as part of 
this symposium issue summarizes unique 
cAMP-responsive sequences (CRS) in the 
bovine C Y P 1 7  and C Y P l l A  genes and in the 
human CYP21B gene [1]. 
REGULATION OF C Y P I I A ,  C Y P I 7  AND 3.~HSD 
EXPRESSION IN MOUSE LEYDIG CELLS 
Earlier studies from our laboratory demon- 
strated that in mouse Leydig cell cultures cAMP 
is essential for de novo synthesis of CYPI7, but 
not for CYP11A. In the absence of cAMP, de 
novo synthesis of CYP 17 ceases, while CYP 11A 
exhibits high basal synthesis [2]. We have also 
shown that steroid hormones negatively 
regulate de novo synthesis of CYP17[3] and 
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Fig. 2. Specificity of glucocorticoid-mediated repression of P450scc synthesis in mouse Leydig cells. Leydig 
cells were incubated for 4 days before treatment for 24 h with 0. I/a M dexamethasone (DEX), 0.1/aM 
cortisol (F), 0.1/aM corticosterone (B), 2 #M testosterone (T), or 0.05 #M estradiol (E2). Cultures were 
radiolabeled, and P450sec was immunoisolated from 30 #g lysate. 35S-labeled P450scc was quantitated 
by densitometry, and relative units are expressed above each lane. CON, control. From Hales and 
Payne [4]. 
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Fig. 3. Effect of cAMP and dexamethasone on P450scc 
synthesis and mRNA levels in mouse Leydig cells. Cultures 
were treated for 6 days before the initiation of treatment for 
24h with 0.1 tiM dexamethasone (Dex) or 50/tM 8-Br- 
cAMP (cAMP) and P450scc synthesis and mRNA levels 
were quantitated in parallel in three separate experiments. 
P450scc de novo synthesis was measured as described in Fig. 
2 and mRNA was quantitated by dot blot hybridization. 
CON, nontreated controls. From Hales and Payne [4]. 
CYP11A [4] in normal mouse Leydig cells. The 
repression is specific for a particular steroid 
hormone and for the enzyme. Glucocorticoids 
repress both basal and cAMP-stimulated 
CYP11A protein synthesis and mRNA levels as 
shown in Figs 2 and 3 [4], while testosterone 
represses cAMP-induced synthesis of CYP17 [2]. 
The repression by these steroids can be pre- 
vented by the appropriate steroid antagonist. 
RU486 prevents the repression caused by dexa- 
methasone [4] while hydroxyflutamide prevents 
the repression caused by testosterone [3]. These 
findings indicate that the  repression caused by 
these steroid hormones is mediated via their 
respective steroid receptors. Estradiol has no 
effect on the synthesis of CYPl lA (Fig. 2) 
or CYP1713,4]. In contrast to our finding 
in normal Leydig cells, the glucocorticoid, 
dexamethasone, stimulates both de novo 
synthesis and steady state levels of CYPl lA 
mRNA in MA-10 tumor Leydig cells [5]. The 
stimulatory effect of dexamethasone in MA-10 
cells is additive to the stimulatory effect of 
cAMP[5]. Although glucocorticoids are not 
produced in Leydig cells, glucocorticoid recep- 
tors have been demonstrated in interstitial cells 
of the rat testis [6]. Increased production of 
glucocorticoids in pathologic conditions of the 
adrenal cortex, such as Cushing's syndrome can 
be associated with reproductive dysfunction, 
including decreased circulating testosterone [7]. 
The studies from our laboratory have 
identified two sites in the biosynthetic pathway 
from cholesterol to testosterone, CYPl lA 
and 3flHSD, where increased circulating con- 
centrations of glucocorticoids could act to de- 
crease testicular testosterone production [4, 8]. 
In more recent studies we have investigated 
cAMP induction and steroid repression of 
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Fig. 4. Effect of cAMP and androgens on 3/~HSD and CYPI7 (P45017=) mRNA levels. Mouse Lcydig 
cells were incubated for 6 days before treatment for 24 h with increasing concentrations of cAMP (cA) 
in the presence or absence of 0.5 mM aminoglutethimide (AG) and where indicated 2/~M mibolerone 
(Mib) or 2/zM testosterone (T). Total cytoplasmic RNA was isolated and 7/~g were subjected to 
Northern analysis and hybridized sequentially with 3flHSD, Cypl7 and /~-actin DNA probes. From 
Payne and Sha [8]. 
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Fig. 5. Effects of mibolerone, dexamethasone, and estradiol on 3flHSD and CYP17 (P45017~) mRNA 
levels. Mouse Leydig cells were incubated and treated as described in Fig. 4. Mibolerone (Mib; 2/~M), 
dexameth~one (Dex; 100 nM), estradioi (E2; 100 nM), and (E2*; 1 #M) were added to cAMP- plus 
aminoglutethimide (AG)-treated cultures where indicated. Total cytoplasmic RNA was isolated and 7 #g 
were subjected to Northern analysis and hybridized, as described in Fig. 4. From Payne and Sha [8]. 
CYP17 and 3flHSD mRNA levels in mouse 
Leydig cell cultures. Purified mouse Leydig cells 
are incubated in a serum-free medium contain- 
ing 0.1% bovine serum albumin and 500 gg/ml 
insulin. Cultures are maintained for 6 days prior 
to treatment. Figure 4 illustrates that in the 
absence of  treatment w i t h  cAMP, CYP17 
mRNA levels are undetectable while 3flHSD 
mRNA is expressed at high basal levels, 
similar to what is found with CYP11A mRNA 
(Fig. 3). Treatment of  Leydig cell cultures for 
24 h with increasing concentrations of  cAMP 
(50-500 g M) markedly decreases the levels of  
3flHSD mRNA relative to that of  untreated 
control cultures while CYP17 mRNA levels are 
induced [8]. The addition of  aminoglutethimide, 
an inhibitor of  cholesterol metabolism, together 
with cAMP results in marked increases in both 
CYP17 and 3flHSD mRNA levels relative to 
untreated control cultures or to cultures treated 
only with cAMP (Fig. 4). This observation 
suggests that testosterone, which is produced in 
high amounts during treatment of  normal 
mouse Leydig cell cultures with cAMP, re- 
presses the cAMP induction of  both 3flHSD 
and CYP17 mRNA's  [8]. T o  test this hypoth- 
esis, exogenous testosterone or the androgen 
agonist, mibolerone, was added to cultures 
treated with cAMP plus aminoglutethimide. 
Data presented in Figs 4 and 5 demonstrate that 
testosterone markedly represses the cAMP 
induction of  3flHSD and CYP17 mRNA and 
that this effect of  testosterone can be mimicked 
by the androgen agonist, mibolerone. The 
repression of  CYP17 and 3flHSD mRNA by 
testosterone is not a general effect of  steroids 
or a general effect of  testosterone on all 
steroidogenic enzymes. Estradiol does not 
repress CYPI7 or 3flHSD expression (Fig. 5 
and Ref. [8]). Dexamethasone represses basal 
(Fig. 6) and cAMP-induced levels of  3flHSD 
mRNA, but not of  CYP17 mRNA (Fig. 5 and 
Ref. [8]). 
The requirement for newly synthesized pro- 
teins in mediating cAMP induction of CYP17 
and 3flHSD differs from that of  CYP11A (Fig. 
6). Inhibition of protein synthesis for 24 h by 
the addition of  cyclobeximide to Leydig cell 
cultures 30m in before treatment completely 
suppressed both basal and cAMP-induced 
expression of  3flHSD mRNA. Cycloheximide 
also markedly suppressed the cAMP induction 
of  CYP17 mRNA. In contrast, the same treat- 
ment with cycloheximide did not suppress 
cAMP induction of  CYPI 1A mRNA, however, 
basal expression was reduced. 
The role of  protein synthesis and the time 
required for maximal cAMP induction of  
CYP17 and C Y P l l A  mRNA was investigated 
in greater detail [5]. Determination of  cAMP- 
stimulated mRNA levels of  CYP17 and 
CYP11A in the same Leydig cell cultures at 6, 
12 and 24h following treatment with cAMP 
in the presence or absence of  cycloheximide 
resulted in the following observations: (1) 
cAMP induction of  C Y P I l A  mRNA is slow, 
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with the greatest increase over basal levels 
occurring between 12 and 24h; (2) cAMP- 
induced increases in CYPl lA  mRNA at 12 
and 24 h were not prevented by the addition 
of cycloheximide, while basal expression was 
reduced approx. 50%; (3) the temporal pattern 
of cAMP induction of CYP17 was very similar 
to that of CYPI1A, a marked increase in 
CYP17 mRNA levels was observed between 
12 and 24 h; (4) inhibition of protein synthesis 
markedly suppressed cAMP induction of 
CYP17 at all time intervals examined[8]. 
These data indicate that newly synthesized 
proteins are required for cAMP induction of 
CYP17 and 3flHSD mRNA levels, but not 
for CYPl lA mRNA. Furthermore, maximal 
induction by cAMP of CYP17 and CYPl lA  
mRNA takes several hours. This type of 
response is characteristic of genes whose 
induction by cAMP is mediated by newly 
synthesized proteins [9]. The results with 
cycloheximide, however, indicate that cAMP- 
induced increases in CYPl lA mRNA 
do not require newly synthesized proteins. 
These findings indicate that cAMP-induced 
increases in these two P450 mRNA's in 
normal mouse Leydig cells occur by a different 
mechanism(s). 
The role of protein synthesis in mediating 
cAMP induction of CYP17 and CYPl lA has 
been studied in a variety of steroidogenic cells 
from different species. The results appear to be 
dependent on the cell type and experimental 
conditions. John et al. [10] and Zuber et al. [11] 
reported that in cultures of bovine adrenocorti- 
cal cells cycloheximide prevented the cAMP 
induction of CYPl lA and CYP17 mRNA. 
These results indicate that in bovine adrenal 
cells newly synthesized proteins are required for 
the cAMP induction of both CYP17 and 
CYPl lA mRNA. More recently, however, the 
same laboratory studied chimeric reporter gene 
constructs containing the 5' cAMP responsive 
sequences of either bovine C Y P I I A  or C Y P I 7  
transiently transfected into bovine adrenocorti- 
cal cells or Y-1 mouse adrenal tumor 
cells [12, 13]. Inhibition of protein synthesis by 
cycloheximide did not reduce cAMP-induced 
expression of these transiently transfected re- 
porter genes containing either C Y P I I A  or 
CYP17  sequences. The reason for the dis- 
crepancy of the effect of cycloheximide on the 
expression of endogenous bovine genes and that 
of reporter genes is not obvious at this time. 
Other reports on the role of newly synthesized 
proteins in mediating cAMP induction of 
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Fig. 6. Effect of inhibition of protein synthesis on the expression of 3flHSD, CYP17 (P45017~) and 
CYP11A (P450scc) mRNA. Leydig cells were incubated and treated as described in Fig. 4. Cycloheximide 
(CHX; 10 #g/ml) was added 30rain before addition of 50 #M cAMP (cA) or 100 nM dexamethasone 
(Dex). CHX was added to untreated control cultures (Con) at the same time as it was added to the other 
cultures. After 24h, total RNA was isolated and subjected to Northern analysis and hybridized 
sequentially with 3flHSD, Cypl7, Cyplla and fl-actin eDNA probes. From Payne and Sha [8]. 
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Fig. 7. MA-10 Leydig tumor cells do not express CYP17 
mRNA. Total cytoplasmic RNA was extracted from 
Metrizamide gradient-purified Leydig cells or from MA-10 
Leydig tumor cells and increasing amounts of RNA, as 
indicated, were subjected to Northern analysis and hy- 
bridized sequentially with Cyplla (P450scc) and Cypl7 
(P45017=) DNA probes. 
CYPllA mRNA do not show a consistent 
pattern. Cycloheximide inhibition of cAMP- 
stimulated increases in CYP11A mRNA 
was reported in the transformed human tro- 
phoblastic cell line JEG-3 [14], but was not 
observed for CYPllA in cultures of human 
granulosa cells[15]. We previously reported 
that cAMP- and dexamethasone-induced in- 
creases in CYPllA mRNA are blocked 
by cycloheximide in MA-10 tumor Leydig cells 
in contrast to normal mouse Leydig cells [16]. 
No effect of cycloheximide was observed on 
basal levels of CYPllA mRNA. In contrast 
to our results in MA-10 cells, Mellon and 
Vaise[17] reported that cycloheximide does 
not inhibit cAMP-stimulated increases in 
CYPllA mRNA in this Leydig cell line, but 
decreases basal CYPllA mRNA levels. The 
differences in the two studies are probably due 
to differences in the time cells were exposed to 
cycloheximide, since in normal Leydig cells 
we observed an effect of cycloheximide on 
cAMP induction of CYPllA mRNA at 6h 
but not after 12 or 24 h of treatment [8]. The 
role of newly synthesized protein mediators 
in cAMP-induced transcription of the genes 
encoding CYP11A and CYP17 requires further 
investigation. 
ISOLATION AND CHARACYERIZATION OF 
MOUSE Cyp17 AND IDENTIFICATION 
OF A cAMP-RESPONSIVE REGION 
To investigate the regulation of expression of 
Cypl 7gene at the transcriptional level, we have 
isolated the mouse structural gene encoding 
CYP17. Two genomic clones containing the 
entire coding region and approximately 10 
kilobases (kb) of 5' flanking sequences of Cyp 17 
were isolated and characterized [18]. To identify 
sequences involved in the cAMP regulation of 
mouse CypI 7 and to investigate further 
the mechanism by which cAMP induces trans- 
cription of Cypl7, fragments 5' of the coding 
region were subcloned into vectors containing 
the chloramphenicol acetyl transferase (CAT) 
reporter gene [18]. Constructs containing differ- 
ent lengths ~ of 5' upstream sequences up to 
4.5 kb were transiently transfected into MA-10 
tumor Leydig cells and treated with cAMP. 
MA-10 tumor Leydig cells do not express 
endogenous CYP17 mRNA as shown in Fig. 7, 
and thus produce progesterone rather than 
testosterone when stimulated with human 
chorionic gonadotropin [19] or with cAMP [5]. 
cAMP response of the constructs was deter- 
mined by measuring CAT activity (amount of 
chloramphenicol acetylated with [3H]acetate) in 
the cell extracts. Figure 8 illustrates that 
treatment of transfected MA-10 cells with 
cAMP showed the greatest increase in Cypl 7- 
CAT activity in the construct containing 1.1 kb 
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Fig. 8. Localization of Cypl7(P45OtT~) 5' regulatory regions 
responsible for cAMP induction. Plasmids were constructed 
by subcloning different size kilobase (kb) fragments 5' of the 
Cypl7 coding region into the multiple cloning site of a 
promoterless plasmid, pGSVOCAT t. pGSVOCAT t was 
constructed by inserting the chloramphenicol acetyltrans- 
ferase (CAT) reporter gene into pGem7Zf+. A terminator 
fragment (t) containing an SV40 poly-A addition signal was 
inserted into the pGcm-CAT upstream of the multiple 
cloning region. MA-10 Leydig tumor cells were transfected 
transiently with the indicated constructs (5/zg DNA). After 
24 h cells were treated for 12 h in the absence (open bars) or 
presence (closed bars) of 500/J M 8-Br-cAMP. CAT activity 
was measured in cell extracts by measuring the amount 
of [3H]acetylated chloramphenicol produced during 2 h. All 
cultures were cotransfected with 5/zg of SV2#-gal and CAT 
activity is expressed relative to #-galactosidase activity 
~-ga]) [8]. 
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Fig. 9. Time course of cAMP induction of CypI7-CAT 
expression in MA-10 cells. Cells were transfected transiently 
with the 1.1 kb CypI7-CAT construct as described in Fig. 
8. Cells were treated in the absence (open bars) or presence 
of 500/~M cAMP (closed bars) for the time indicated. 
activity was detected in the construct containing 
0.3 kb of 5' flanking sequences, and cAMP- 
induced expression of the constructs containing 
2.5 and 4.5 kb of the 5' flanking region was 
less than that observed with the 1.1 kb con- 
struct. These data demonstrate that the cAMP- 
responsive region is between 0.3 and 1.1 kb. 
Expression in the absence of cAMP treatment 
of the MA-10 cells results in very low expression 
of the CypI7-CAT constructs similar to ex- 
pression of the endogenous Cyp l7  in normal 
Leydig cells. The observation that MA-10 
cells express the transfected CyplT-CAT con- 
structs when stimulated with cAMP, even 
though they do not express endogenous Cyp 17, 
demonstrates that these cells contain the 
transacting factors essential for expression of 
this gene. 
To establish the concentration of cAMP 
necessary for maximal induction of expression 
of the Cypl 7-CAT construct containing 1.1 kb 
of 5' flanking region, MA-10 cells transfected 
with this construct were treated with increasing 
concentrations of 8-Br-cAMP (0-1000 # M). 
Maximal expression of CypI7-CAT was ob- 
served at a concentration of 500 #M cAMP. 
No further increase was seen in cells treated 
with 1000 # M cAMP. The time course of induc- 
tion of the 1.1 kb CypI7-CAT construct by 
500 #M cAMP is shown in Fig. 9. No increase 
in CAT expression was seen after 2h of 
treatment. After 4 h of treatment with cAMP 
Cypl7-CAT expression was increased by ap- 
prox. 3-fold with a maximal increase of 7.5-fold 
seen after 12 h. The relatively long time required 
for the initial and the maximal increase in 
cAMP-induced Cypl 7-CAT expression is 
similar to the long time required for maximal 
cAMP induction of the endogenous gene in 
Leydig cells[8] and is consistent with the 
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Fig. 10. Identification of sequences responsible for cAMP induction of the 5' flanking region of the mouse 
Cypl7gene. Cells were transfected with the CypI7-CAT construct indicated on the left-hand side of the 
figure and treated for 12 h in the absence (open bars) or the presence (closed bars) of 500 gM cAMP as 
described in Fig. 8. 
902 A.H.  PAYNE et al. 
> 
o 10 g 
I-I Control 
[ ]  DHT 




Fig. 1 !. Transfection of the mAR into MA-10 cells. MA-10 
cells were transfected by the calcium phosphate precipi- 
tation method with either the 3 x (HRE)tkCAT reporter 
plasmid (5 #g) containing a trimer of a hormone-response 
element for the Sip gene fused to the herpes simplex virus 
thymidine kinase (tk) promoter and the bacterial CAT gene, 
or with the tkCAT reporter plasmid (5/zg) lacking the 
HREs, in the presence or absence of the mAR expression 
plasmid (4/zg). After 24 h of incubation cells were un- 
treated, or treated with 2 #M DHT for 12 h as indicated. 
The CAT activity was determined in cell extracts by measur- 
ing the amount of [3H]acetylated chloramphenicol produced 
during 2 h. All cultures were cotransfeeted with 3/zg of 
SV2/Lgal and results are expressed relative to fl-galactosi- 
dase activity (fl-gal). 
hypothesis that the mouse Cypl7 gene belongs 
to the class of cAMP-responsive genes that 
require a newly synthesized protein(s) and that 
cAMP-induced increases are probably not me- 
diated by the ubiquitous CRE-binding protein 
(CREB) [9]. 
To further define sequences essential for 
cAMP induction, additional deletions of the 
l.l kb 5' flanking construct were made. The 
results of those studies are shown in Fig. 10. 
Very low expression is seen in the construct 
containing -245  bp, with a marked increase 
seen in the construct containing up to - 346 bp. 
This construct also shows a small increase 
in basal expression. There appears to be a 
further increase in cAMP-induced expression in 
the constructs containing between -435  and 
- 1021 bp. These data indicate that the cAMP- 
responsive region is between -245  and -346  
with possibly additional enhancement of the 
cAMP-induced expression by sequences found 
between -435  and - 1021 bp. 
When the sequence of the mouse Cypl7 
cAMP-responsive region ( -  245 / -  346) is 
aligned to the cAMP-responsive sequences of 
the human [20] and bovine [21] genes, no appar- 
ent homology was observed among these three 
CYP17cAMP-responsive regions [18]. Previous 
studies by Brentano et al.[22] on human 
CYPI 7-CAT constructs transfected into MA- 
10 Leydig cells showed very low expression of 
the CAT reporter gene and a minimal cAMP 
response. These findings with the human CYP! 7 
constructs are in sharp contrast to the data 
we observed with the mouse CypI7-CAT 
constructs transfected into MA-10 Leydig cells, 
suggesting that there are species-specific and 
perhaps tissue-specific factors necessary for 
cAMP-induced expression of the Cypl7 and 
CYPI 7 genes. 
REPRESSION OF cAMP-INDUCED 
EXPRESSION OF Cypl7 BY THE MOUSE 
ANDROGEN RECEPTOR 
Previous studies from our laboratory 
demonstrated that testosterone or the androgen 
agonist mibolerone repressed cAMP induction 
of CYP17 protein synthesis[3] and mRNA 
levels [8] in normal mouse Leydig cells. The 
repression of cAMP-induced increases by 
testosterone could be prevented by the androgen 
antagonist, hydroxyflutamide [3]. These data 
indicated that endogenous testosterone pro- 
duced during cAMP induction of CYP17 
negatively regulates the rate of CYP17 protein 
synthesis and mRNA levels by an androgen 
receptor-mediated mechanism [3, 8]. To investi- 
gate whether this repression of cAMP-induced 
CYP17 protein synthesis and mRNA levels 
by an androgen receptor-mediated mechanism 
occurred at the level of transcription, exper- 
iments were carried out using the Cypl7-CAT 
construct containing 4.5kb of 5' flanking 
30I I-I ConVol 
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Fig. 12. Effect of mAR on cAMP-induced expression of 
Cyp17. MA-10 cells were cotransfected with the 4.5kb 
Cyp I ;'-CAT construct (5/~g) prepared as described in Fig. 
7, SV2p-gal (5/~g), and increasing amounts of the mAR 
expression plasmid as indicated. Cells were treated as de- 
scribed in Fig. I 1 with 500 pM 8-Br-cAMP or cAMP plus 
2/IM DHT. 
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region. The initial experiment examined 
whether the MA-10 tumor Lcydig cells contain 
endogenous androgen receptors. 
To test for the presence of endogenous andro- 
gen receptor, MA-10 cells were transiently 
transfected with a construct containing 3 copies 
of androgen-responsive sequences [3 x (HRE)] 
isolated from the androgen-responsive sex- 
limited protein (Sip) gene upstream of the 
thymidine kinase (tk) promoter fused to the 
CAT reporter gene [3 x(HRE)tkCAT][23]. 
This construct has been shown to interact with 
the mouse androgen receptor and its expression 
is dependent on androgen. Treatment of MA-10 
cells transfected with the 3 x (HRE)tkCAT 
plasmid with the androgen dihydrotestosterone 
(DHT) did not increase CAT activity suggesting 
that MA-10 cells do not contain endogenous 
androgen receptor (Fig. 11). We therefore co- 
transfected the MA-10 cells with a mouse an- 
drogen receptor (mAR) expression vector [24]. 
Cotransfection of the 3 x (HRE)tkCAT with 
the mAR expression vector followed 18 h later 
by treatment with DHT for 12 h resulted in a 
3- to 4-fold increase in CAT activity (Fig. 11). 
DHT treatment of cells cotransfected with the 
mAR and with the tkCAT reporter gene lacking 
the 3 x (HRE) did not result in an increase in 
CAT activity. 
To examine the effect of androgens on cAMP- 
induced expression of Cypl 7-CAT, MA-10 cells 
were cotransfected with the 4.5 kb Cypl7-CAT 
construct (5 #g) and with increasing amounts of 
the mAR (0-4#g) and treated for 12h with 
cAMP or cAMP plus DHT. Figure 12 illustrates 
that increasing amounts of mAR caused a dose- 
dependent repression of cAMP-induced Cyp 17- 
CAT expression in the absence of DHT. The 
addition of DHT resulted only in a small further 
decrease in CAT activity of ~ 25%. No effect of 
DHT was observed in the absence of cotrans- 
fected mAR. The observed dose-dependent 
decrease in cAMP-induction of Cyp17-CAT 
expression with increasing amounts of mAR 
alone and the small additional decrease ob- 
served with the addition of DHT suggest that 
cAMP has the capacity to activate the androgen 
receptor. To test this hypothesis, the 
3 x (HRE)tkCAT construct was cotransfected 
with 4 #g mAR into MA-10 cells and cells were 
treated with 500#M cAMP, 2#M DHT or 
cAMP plus DHT. Treatment with cAMP 
resulted in a similar increase in the 
3 x (HRE)tkCAT expression as was observed 
when cells were treated with DHT only. Treat- 
ment with cAMP plus DHT resulted in essen- 
tially the same amount of induction as with 
either compound alone (Fig. 13). These data 
suggest that cAMP as well as DHT can activate 
the mAR. Furthermore, these data suggest that 
activation of the androgen receptor involves 
phosphorylation of the receptor. This sugges- 
tion is supported by a report by van Laar 
et al. [25] that steroid hormone-induced phos- 
phorylation of the human androgen receptor 
was accompanied by transformation of the 
receptor protein to a tight nuclear binding form. 
Thus, our observations in the present study and 
the report by van Laar et al. are consistent with 
the proposal that activation of the androgen 
receptor involves phosphorylation. Denner 
et al. [26] reported similar findings of cAMP or 
progesterone activation of the chicken pro- 
gesterone receptor as we observed with the 
mAR. These authors showed that progesterone 
receptor-mediated transcription of a target 
gene, in transiently transfectcd CV1 cells, was 
increased by treatment of cells with 8-Br-cAMP 
in the absence of the steroid ligand, progester- 
one. This finding indicates that the chicken 
progesterone receptor as well as the mAR can 
be activated by cAMP as well as by their 
respective steroid ligands. Future studies should 
determine whether cAMP activation of steroid 
receptors is an alternate mechanism for activat- 
ing all steroid receptors or whether cAMP acti- 
vation is specific for certain steroid receptors. 
Data presented in this section indicate that 
the androgen receptor-mediated repression of 
CYP17 protein synthesis and mRNA levels 
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Fig. 13. Activation of the androgen receptor by cAMP or 
DHT. MA-10 cells were cotransfccted with the 
3 x(HRE)tkCAT plasmid (5#g), the mAR (4#g) and 
SV2fl-gal (3 #g) as described in Fig. 11. Cells were untreated 
or treated for 12h v, ith 2 # M  DHT, 500#M cAMP or 
cAMP plus DHT. 
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action of the androgen receptor with DNA 
sequences located in the 5' flanking region of the 
C yp 17 gone. 
LEYDIG CELL SPECIFIC SEQUENCES FOR THE 
EXPRESSION OF MOUSE C y p l l a  
In a recent study on the analysis of the 
promoter region of the gone encoding mouse 
Cyplla, it was found that constructs containing 
1500 bp of 5' flanking region, when transfected 
into mouse Y-I adrenocortical cells, exhibited 
high levels of expression of a growth hormone 
reporter gone [27]. In contrast, the same con- 
struct showed very low expression in mouse 
MA-10 Leydig cells. To examine whether 
additional sequences are necessary for the ex- 
pression of the Cyplla gone in Leydig cells, a 
32p-labeled probe containing + 150 to - 1300 of 
the mouse Cyplla gone (a gift from Dr Keith 
Parker) was used to screen an EMBL-3 mouse 
genomic library. A clone containing 
,,,13,000 bp of 5' flanking sequences plus 
4000 bp of the structural gone was characterized 
by restriction mapping and partial sequencing. 
Constructs containing different lengths of 5' 
flanking sequences up to approx. -8000 bp 
were subcloned into vectors containing the CAT 
reporter gone and transiently transfected into 
MA-10 Leydig cells or Y-1 adrenocortical cells. 
Expression with the different constructs in each 
cell type was determined by measuring the CAT 
activity in the cell extracts. The results of this 
study are shown in Fig. 14. Basal expression of 
Cyplla in Y-1 adrenocortical cells was 
greatest in the construct containing -1200 bp. 
No additional increase in expression of Cyplla 
was observed in Y-1 adrenocortical cells 
with constructs up to - 5000 bp of  5' flanking 
sequences relative to a minimal promoter con- 
taining -198bp .  In Leydig cells, very little 
expression of the Cyplla gone constructs was 
observed in plasmids containing up to 2500 bp 
5' of the coding region. As shown in Fig. 14, a 
marked increase in expression in MA-10 Leydig 
cells was observed with a construct that con- 
tained 5000 bp 5' of the coding region. This 
observation suggests that sequences between 
-2500 and - 5 0 0 0 b p  are essential for ex- 
pression of Cyplla in Leydig cells. To examine 
this finding further, a plasmid was constructed 
in which sequences between - 1 9 8 b p  and 
-2500 bp were deleted. The data presented in 
Fig. 14 demonstrate that sequences between 2.5 
and 5.0 kb 5' of the coding region of Cyp 1 la are 
essential for expression in Leydig cells but not 
in adrenal cells. Further deletion studies are 
underway to localize more precisely the Leydig 
cell-specific sequences. 
Previous studies from this laboratory 
indicated that Cyplla expression was regulated 
differently in Leydig cells and adrenal glands of 
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Fig. 14. Identification of Lcydig cell specific sequences for the expression of mouse C y p l l a .  Different size 
fragments 5' of the C y p l l a  coding region were subcloned into the multiple cloning site of a promoterless 
plasmid (pGSVOCAT) as described in Fig. 8, except that pGSVOCAT does not contain the terminator 
fragment. The C y p l l a  constructs are s h o w n  on the left hand side of the figure. 10#g of the indicated 
plasmid and 5#g  of SV2fl-gal were transfccted transiently into MA-10 I.~ydig tumor cells or Y-I 
adrenocortical tumor cells. Cells were harvested 36 h following transfcction and CAT activity was 
determined in cell extracts by measuring the amount of [3H]acetylated chloramphenicol produced during 
2 h for MA-10 cells or I h for Y-I cells. Transfcction efficiency was corrected for/~-galactosidas¢ activity. 
CAT activity is expressed relative to the promoterless pGSVOCAT plasmid. 
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the mouse [28]. Using inbred strains of mice, we 
identified two strains of mice, RF/J and SWR/J, 
whose Leydig cells exhibited a high amount of 
immunoreactive CYPl lA  and two strains, 
DBA/2J and C3H/HeJ, whose Leydig cells 
exhibited a low amount of CYPI 1A. The pat- 
tern of expression of CYP11A in adrenal glands 
from the same mice was different from that in 
Leydig cells. The amount of CYPl lA  was 
highest in the adrenal glands of C3H/HeJ 
and lowest in SWR/J[28]. These findings 
suggested that tissue specific factors in adrenal 
and/or Leydig cells influence the expression of 
this enzyme. In a subsequent study, in which 
we investigated the relationship of the Cyplla 
structural gene and the amount of CYPl lA  
protein, we demonstrated that quantitative 
differences in mouse Leydig cell CYPl lA 
protein are determined either by Cyplla or 
by a closely linked locus [29]. No evidence 
could be found that this locus determined 
quantitative differences in mouse adrenal 
CYP11A (C. J. Nolan and A. H. Payne, unpub- 
lished data). These studies provide additional 
evidence that expression of CYPIlA in Leydig 
and adrenal cells is regulated by different 
mechanisms. 
CONCLUSIONS 
This chapter reviews the complexity of the 
regulation of expression of the enzymes in- 
volved in testosterone production in Leydig 
cells. The three major enzymes studied, 
CYP11A, CYP17 and 3~HSD are differentially 
regulated. Maximal levels of mRNA for the 
three enzymes requires cAMP. There is high 
basal expression of both CYP11A and 3/~HSD 
mRNA, while expression of CYP17 mRNA is 
absolutely dependent on chronic stimulation by 
cAMP. Endogenously produced testosterone in 
normal mouse Leydig cells acting via the andro- 
gen receptor negatively regulates expression of 
cAMP-induced CYP17 as well as 3~HSD 
mRNA, while glucocorticoids acting via the 
glucocorticoid receptor repress CYPl lA  and 
3f/HSD mRNA levels. The mechanism by 
which cAMP increases expression of the three 
enzymes in normal mouse Leydig cells is differ- 
ent. Newly synthesized proteins are essential 
for cAMP induction of CYPI7 and 3/~HSD 
mRNA, but not for CYPIlA mRNA. In the 
absence of protein synthesis for a 24 h period, 
basal levels of 3//HSD mRNA are completely 
repressed while basal levels of CYP11A mRNA 
are reduced by 50% indicating that rapidly 
turning over proteins are required for basal 
expression of 3//HSD and CYPl lA  mRNA. 
Data are presented identifying the cAMP- 
responsive region in the 5' flanking sequences of 
mouse CyplZ Constructs containing different 
length fragments of the Cyp 17 5' flanking region 
fused to the CAT reporter gene were transfected 
into MA-10 tumor Leydig cells, and sequences 
between -245  and -346  were identified as the 
cAMP-responsive region. We demonstrate that 
12 h are required for cAMP to maximally in- 
crease CypI7-CAT expression and that no in- 
crease in expression is observed at 2 h with only 
a small increase at 4 h. This observation is 
consistent with the results observed in normal 
mouse Leydig cells that cAMP induction of 
CYP17 mRNA requires newly synthesized pro- 
teins. Furthermore, we demonstrate that repres- 
sion by the androgen receptor of cAMP 
induction of Cypl7occurs at the level of tran- 
scription. In addition, data are presented that 
indicate that the mAR can be activated by 
cAMP in the absence of the androgen ligand. 
This observation provides evidence for a novel 
mechanism of steroid receptor activation which 
may lead to new theories about the transform- 
ation of steroid receptors from an inactive form 
to an active DNA-binding form. 
Evidence is presented for the presence of 
specific sequences in the 5' flanking region of the 
Cyplla structural gene that are required for 
Leydig cell expression. These data indicate 
that there are tissue-specific factors that are 
necessary for expression of CYP11A in Leydig 
cells and in adrenal glands. 
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